Picture of daVictus logo

DVT daVictus News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro CapNeutral

REG - daVictus Plc - SUPPLEMENTARY PROSPECTUS PUBLICATION




 



RNS Number : 1928F
daVictus plc
05 March 2020
 

5 March 2020

 

daVictus plc

("daVictus" or "Company")

 

SUPPLEMENTARY PROSPECTUS PUBLICATION

 

The board of daVictus Plc (LON: DVT) is pleased to announce that a supplementary prospectus relating to: (i) the Company's conditional acquisition by way of a reverse takeover of the intellectual property rights in a restaurant concept owned by Typical Dutch N.V. ("TDNV");  (ii) the placing of 900,000 new ordinary shares of no par value at 15 pence per share; and (iii) the admission of 12,150,00 ordinary shares of no par value to the Official List (by way of Standard Listing under Chapter 14 of the Listing Rules) and to trading on the London Stock Exchange's Main Market for listed securities ("Admission") was approved by the Financial Conduct Authority on 5 March 2020.

 

The supplementary prospectus has been published in electronic form and will shortly be available on the Company's website http://www.davictus.co.uk/page/uploads/readmission-supplementaryprospectus.pdf and from the Company's registered office at JTC PLC, 28 Esplanade, St Helier JE1 8SB, Jersey.

 

In accordance with the Listing Rules, the listing of the enlarged issued share capital, under the name of daVictus Plc, is expected to occur at 8.00 a.m. on 10 March 2020.

 

A further announcement will be made on Admission.

 

Dealing Code

 

ISIN : JE00BYY5RQ34

SEDOL : BYY5RQ3

TIDM : DVT

 

End

 

For further information, please contact:

 

Sara Chawankon (Ms)

Investor Relations Team

ir@davictus.co.uk

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPUPURPWUPUGAA

Recent news on daVictus

See all news